Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 28 for:    pandemrix AND influenza vaccine

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). (LAIV Immuno)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02143882
Recruitment Status : Completed
First Posted : May 21, 2014
Last Update Posted : January 16, 2018
Sponsor:
Collaborator:
Institute of Child Health
Information provided by (Responsible Party):
Prof. Elizabeth Miller, Public Health England

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 31, 2017
Actual Study Completion Date : March 31, 2017